(Q34375192)

English

Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

author name string

Amsden GW

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

8 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

10-21

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Macrolides for the treatment of Pseudomonas aeruginosa infections?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Airway biofilm disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Therapeutic possibilities of long-term roxithromycin treatment for chronic diffuse sclerosing osteomyelitis of the mandible

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Guidelines for the management of community-acquired pneumonia in Saudi Arabia: a model for the Middle East region

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Quality of care, process, and outcomes in elderly patients with pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Clarithromycin attenuates mastectomy-induced acute inflammatory response.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Effect of Macrolides as Part of Initial Empiric Therapy on Length of Stay in Patients Hospitalized With Community-Acquired Pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH519

21 January 2018

Identifiers

10.1093/JAC/DKH519

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

release_dppvmlblxrho3dxlfnqh23dhbi

1 reference

https://api.fatcat.wiki/v0/release/dppvmlblxrho3dxlfnqh23dhbi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34375192&oldid=1960264108"